NEWS

February 27, 2019
Neurogene Appoints Industry Leaders Dr. Sukumar Nagendran and Dr. Serge Stankovic to Board of Directors
Learn more >
February 12, 2019
Neurogene Raises $68.5 Million in Series A Financing to Advance Multiple Programs in Devastating Neurological Diseases
Learn more >
February 7, 2019
Neurogene Announces Presentation of Preclinical Data for Gene Therapies to Treat AGU and CMT4J, Two Rare and Devastating Neurodegenerative Disorders
Learn more >
January 23, 2019
Neurogene Appoints Stuart Cobb, Ph.D. as Chief Scientific Officer
Learn more >

For MEDIA INQUIRIES

Sara Green
sgreen@tenbridgecommunications.com
617-233-1714